TCC missed in apparent interstitial cystitis patients
Today, many patients with apparent interstitial cystitis receive diagnosesbased on the minimally invasive (but not very specific) potassium sensitivitytest and the pelvic pain urgency/frequency (PUF) questionnaire-not throughcystoscopy and hydrodistension under anesthesia, which has been the goldstandard. That means that when the irritative voiding symptoms are in factcaused by transitional cell carcinoma of the bladder, they can be misdiagnosedas IC.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.